Barriers to the Prevention of Insulin Injection-Associated Lipohypertrophy for Individuals with Diabetes

预防糖尿病患者胰岛素注射相关性脂肪增生的障碍

阅读:1

Abstract

AIMS AND OBJECTIVES: This study aimed to explore barriers to preventing lipohypertrophy for individuals with diabetes. DESIGN: A qualitative descriptive design was used. METHODS: 17 individuals with diabetes with LH were interviewed face-to-face in individual semi-structured interviews. Qualitative content analysis was used, and data saturation was achieved. RESULTS: The analysis yielded three primary themes with eight subthemes: lack of knowledge (insufficient health education, forgetfulness, and misconceptions), limited feasibility (several limitations in site rotation, financial pressures in needle replacement, and failure to self-monitor flat LH), and low motivation (low perceived severity and low perceived susceptibility). CONCLUSION: Identifying these barriers provides patients with targeted recommendations or measures to improve LH prevention, further improving self-management at home and diabetes outcomes. RELEVANCE FOR CLINICAL PRACTICE: LH is a common insulin therapy complication that affects insulin absorption and glycemic control. The correct injection technique for preventing LH depends on the effectiveness of insulin therapy in individuals with diabetes. PATIENT OR PUBLIC CONTRIBUTION: 17 individuals with type 2 diabetes who participated in the interviews contributed to this study.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。